Distinguishing physiological versus pathological serum NfL levels in multiple sclerosis will require serial measurements

被引：2
|
作者：
Smets, I. [1 ]
Reyes, S. [1 ]
Giovannoni, G. [1 ,2 ]
机构：
[1] Queen Mary Univ London, Blizard Inst, Barts & London Sch Med & Dent, London, England
[2] Barts Hlth NHS Trust, Royal London Hosp, Dept Neurol, London, England
来源：
MULTIPLE SCLEROSIS AND RELATED DISORDERS | 2020年 / 46卷
关键词：
Neurofilament; Multiple sclerosis; Biomarker; NEUROFILAMENT PROTEIN; LIGHT;
D O I：
10.1016/j.msard.2020.102477
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Serum GFAP and NfL levels in benign relapsing-remitting multiple sclerosis
    Niiranen, Marja
    Kontkanen, Aleksi
    Jaaskelainen, Olli
    Tertsunen, Hanna-Mari
    Selander, Tuomas
    Hartikainen, Paivi
    Huber, Nadine
    Solje, Eino
    Haapasalo, Annakaisa
    Kokkola, Tarja
    Lohioja, Tarja
    Herukka, Sanna-Kaisa
    Simula, Sakari
    Remes, Anne M.
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2021, 56
  • [2] Serum NFL levels should be used to monitor multiple sclerosis evolution - Commentary
    Chitnis, Tanuja
    MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (01) : 21 - 22
  • [3] Serum NfL levels should be used to monitor multiple sclerosis evolution - Yes
    Leppert, David
    Kuhle, Jens
    MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (01) : 17 - 19
  • [4] Serum hepcidin levels in multiple sclerosis
    Bsteh, Gabriel
    Haschka, David
    Tymoszuk, Piotr
    Berek, Klaus
    Petzer, Verena
    Hegen, Harald
    Wurth, Sebastian
    Auer, Michael
    Zinganell, Anne
    Di Pauli, Franziska
    Deisenhammer, Florian
    Weiss, Guenter
    Berger, Thomas
    MULTIPLE SCLEROSIS JOURNAL-EXPERIMENTAL TRANSLATIONAL AND CLINICAL, 2019, 5 (04)
  • [5] NfL and GFAP in serum are associated with microstructural brain damage in progressive multiple sclerosis
    Ammitzboll, C.
    Dyrby, T. B.
    Bornsen, L.
    Schreiber, K.
    Ratzer, R.
    Christensen, J. Romme
    Iversen, P.
    Magyari, M.
    Lundell, H.
    Jensen, P. E. H.
    Sorensen, P. S.
    Siebner, H. R.
    Sellebjerg, F.
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2023, 77
  • [6] Serum GFAP and NfL Levels Differentiate Subsequent Progression and Disease Activity in Patients With Progressive Multiple Sclerosis
    Barro, Christian
    Healy, Brian C.
    Liu, Yanqing
    Saxena, Shrishti
    Paul, Anu
    Polgar-Turcsanyi, Mariann
    Guttmann, Charles R. G.
    Bakshi, Rohit
    Kropshofer, Harald
    Weiner, Howard L.
    Chitnis, Tanuja
    NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION, 2023, 10 (01):
  • [7] Serum neurofilament levels correlate with retinal nerve fiber layer thinning in multiple sclerosis
    Bsteh, Gabriel
    Berek, Klaus
    Hegen, Harald
    Teuchner, Barbara
    Buchmann, Arabella
    Voortman, Margarete M.
    Auer, Michael
    Wurth, Sebastian
    Zinganell, Anne
    Di Pauli, Franziska
    Deisenhammer, Florian
    Khalil, Michael
    Berger, Thomas
    MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (13) : 1682 - 1690
  • [8] High or increasing serum NfL is predictive of impending multiple sclerosis relapses
    Thebault, Simon
    Reaume, Michael
    Furlan, Roberto
    Laroni, Alice
    Uccelli, Antonio
    Freedman, Mark S.
    Marrie, Ruth Ann
    Marriot, James J.
    Booth, Ronald A.
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2022, 59
  • [9] Serum neurofilament light levels correlate with change of olfactory function in multiple sclerosis
    Bsteh, Gabriel
    Berek, Klaus
    Hegen, Harald
    Buchmann, Arabella
    Voortman, Margarete M.
    Auer, Michael
    Wurth, Sebastian
    Zinganell, Anne
    Di Pauli, Franziska
    Deisenhammer, Florian
    Khalil, Micheal
    Berger, Thomas
    MULTIPLE SCLEROSIS JOURNAL-EXPERIMENTAL TRANSLATIONAL AND CLINICAL, 2019, 5 (04)
  • [10] Serum YKL-40 levels in patients with multiple sclerosis
    Donder, Ahmet
    Ozdemir, Hasan Huseyin
    ARQUIVOS DE NEURO-PSIQUIATRIA, 2021, 79 (09) : 795 - 798
12345